0 256

Cited 0 times in

Cited 0 times in

Evaluating the Efficacy of Immune Checkpoint Inhibitors in Elderly Patients: A Systematic Review and Meta-analysis

DC Field Value Language
dc.contributor.authorKim, Han-sang-
dc.date.accessioned2025-02-03T08:01:18Z-
dc.date.available2025-02-03T08:01:18Z-
dc.date.created2026-01-22-
dc.date.issued2025-10-
dc.identifier.issn1064-3745-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/201519-
dc.description.abstractIn this chapter, we outline the steps for designing and conducting a rigorous systematic review and meta-analysis, focusing on the efficacy of immune checkpoint inhibitors (ICIs) in elderly patients. ICIs have improved survival rates in advanced cancers, yet their effectiveness in older populations remains unclear. We detail the essential processes involved in both systematic reviews and meta-analyses. We can evaluate the efficacy of ICIs in elderly patients with advanced cancer, examining outcomes such as overall survival and progression-free survival. © The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature 2025.-
dc.description.statementOfResponsibilityrestriction-
dc.languageEnglish-
dc.publisherHumana Press-
dc.relation.isPartOfMethods in Molecular Biology-
dc.relation.isPartOfMethods in Molecular Biology (Clifton, N.J.)-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.subject.MESHAged-
dc.subject.MESHHumans-
dc.subject.MESHImmune Checkpoint Inhibitors* / therapeutic use-
dc.subject.MESHImmunotherapy / methods-
dc.subject.MESHNeoplasms* / drug therapy-
dc.subject.MESHNeoplasms* / immunology-
dc.subject.MESHNeoplasms* / mortality-
dc.subject.MESHProgression-Free Survival-
dc.subject.MESHTreatment Outcome-
dc.titleEvaluating the Efficacy of Immune Checkpoint Inhibitors in Elderly Patients: A Systematic Review and Meta-analysis-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Internal Medicine (내과학교실)-
dc.contributor.googleauthorKim, Han-sang-
dc.identifier.doi10.1007/978-1-0716-4128-6_11-
dc.relation.journalcodeJ02226-
dc.identifier.eissn1940-6029-
dc.identifier.pmid39348060-
dc.identifier.urlhttps://link.springer.com/protocol/10.1007/978-1-0716-4128-6_11-
dc.subject.keywordAge-
dc.subject.keywordElderly-
dc.subject.keywordImmune checkpoint inhibitor-
dc.subject.keywordImmunosenescence-
dc.subject.keywordImmunotherapy-
dc.subject.keywordMeta-analysis-
dc.subject.keywordSystematic review-
dc.subject.keywordSystemic reviews-
dc.contributor.alternativeNameKim, Han Sang-
dc.contributor.affiliatedAuthorKim, Han-sang-
dc.identifier.scopusid2-s2.0-85205336361-
dc.citation.volume2857-
dc.citation.startPage117-
dc.citation.endPage125-
dc.identifier.bibliographicCitationMethods in Molecular Biology, Vol.2857 : 117-125, 2025-10-
dc.identifier.rimsid91246-
dc.type.rimsART-
dc.description.journalClass1-
dc.description.journalClass1-
dc.subject.keywordAuthorAge-
dc.subject.keywordAuthorElderly-
dc.subject.keywordAuthorImmune checkpoint inhibitor-
dc.subject.keywordAuthorImmunosenescence-
dc.subject.keywordAuthorImmunotherapy-
dc.subject.keywordAuthorMeta-analysis-
dc.subject.keywordAuthorSystematic review-
dc.subject.keywordAuthorSystemic reviews-
dc.type.docTypeBook chapter-
dc.description.isOpenAccessN-
dc.description.journalRegisteredClassscopus-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.